Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Roger McLendon
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Chemicals & Drugs
Living Beings
Procedures
Sign-in to see full Profile
Network (preview)
80
Friedman, Henry
76
Bigner, Darell
51
Friedman, Allan
32
Provenzale, James
30
Herndon, James
28
Sampson, John
28
Rich, Jeremy
25
Reardon, David
23
Bigner, Sandra
21
Quinn, Jennifer
20
Archer, Gary
19
Zalutsky, Michael
16
Gururangan, Sridharan
15
Vredenburgh, James
14
Wikstrand, Carol
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Roger McLendon (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Quinn Jennifer A; Jiang Sara Xiaoyin; Reardon David A; Desjardins Annick; Vredenburgh James J; Friedman Allan H; Sampson John H; McLendon Roger E; Herndon James E; Friedman Henry S
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
Journal of neuro-oncology 2009;95(3):393-400.
-
2009: Choi Bryan D; Archer Gary E; Mitchell Duane A; Heimberger Amy B; McLendon Roger E; Bigner Darell D; Sampson John H
EGFRvIII-targeted vaccination therapy of malignant glioma.
Brain pathology (Zurich, Switzerland) 2009;19(4):713-23.
-
2009: Wang Hui; Lathia Justin D; Wu Qiulian; Wang Jialiang; Li Zhizhong; Heddleston John M; Eyler Christine E; Elderbroom Jennifer; Gallagher Joseph; Schuschu Jesse; MacSwords Jennifer; Cao Yiting; McLendon Roger E; Wang Xiao-Fan; Hjelmeland Anita B; Rich Jeremy N
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Stem cells (Dayton, Ohio) 2009;27(10):2393-404.
-
2009: Quinn Jennifer A; Jiang Sara Xiaoyin; Reardon David A; Desjardins Annick; Vredenburgh James J; Rich Jeremy N; Gururangan Sridharan; Friedman Allan H; Bigner Darell D; Sampson John H; McLendon Roger E; Herndon James E; Walker Amy; Friedman Henry S
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
Neuro-oncology 2009;11(5):556-61.
-
2009: Boskovitz Abraham; McLendon Roger E; Okamura Tatsunori; Sampson John H; Bigner Darell D; Zalutsky Michael R
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab.
Nuclear medicine and biology 2009;36(6):659-69.
-
2009: Quinn Jennifer A; Jiang Sara Xiaoyin; Reardon David A; Desjardins Annick; Vredenburgh James J; Gururangan Sridharan; Sampson John H; McLendon Roger E; Herndon James E; Friedman Henry S
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
Cancer 2009;115(13):2964-70.
-
2009: Horbinski Craig; Dacic Sanja; McLendon Roger E; Cieply Kathy; Datto Michael; Brat Daniel J; Chu Charleen T
Chordoid glioma: a case report and molecular characterization of five cases.
Brain pathology (Zurich, Switzerland) 2009;19(3):439-48.
-
2009: Waldau Ben; McLendon Roger E; Fuchs Herbert E; George Timothy M; Grant Gerald A
Few isolated neurons in hypothalamic hamartomas may cause gelastic seizures.
Pediatric neurosurgery 2009;45(3):225-9.
-
2008: Ray Gregory T; Agarwal Shanti S; McLendon Roger E
A recurrent cerebellar lesion in a young boy.
Brain pathology (Zurich, Switzerland) 2008;18(4):623-7.
-
2008: Gururangan Sridharan; Krauser Jeanne; Watral Melody A; Driscoll Tim; Larrier Nicole; Reardon David A; Rich Jeremy N; Quinn Jennifer A; Vredenburgh James J; Desjardins Annick; McLendon Roger E; Fuchs Herbert; Kurtzberg Joanne; Friedman Henry S
Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
Neuro-oncology 2008;10(5):745-51.
-
2008: Bao Shideng; Wu Qiulian; Li Zhizhong; Sathornsumetee Sith; Wang Hui; McLendon Roger E; Hjelmeland Anita B; Rich Jeremy N
Targeting cancer stem cells through L1CAM suppresses glioma growth.
Cancer research 2008;68(15):6043-8.
-
2008: Maxwell Jill A; Johnson Stewart P; McLendon Roger E; Lister David W; Horne Krystle S; Rasheed Ahmed; Quinn Jennifer A; Ali-Osman Francis; Friedman Allan H; Modrich Paul L; Bigner Darell D; Friedman Henry S
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4859-68.
-
2008: Brat Daniel J; Parisi Joseph E; Kleinschmidt-DeMasters Bette K; Yachnis Anthony T; Montine Thomas J; Boyer Philip J; Powell Suzanne Z; Prayson Richard A; McLendon Roger E;
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.
Archives of pathology & laboratory medicine 2008;132(6):993-1007.
-
2008: Parisi Joseph E; Miller Dylan V; Boyer Philip J; Brat Daniel J; Cochran Elizabeth J; Cohen Mark L; Demasters Bette K; Dolinak David; McComb Rodney D; McLendon Roger E; Powell Suzanne Z; Prayson Richard A; Vinters Harry V; Yachnis Anthony T;
Protocol for the examination of specimens from patients with tumors of the brain/spinal cord.
Archives of pathology & laboratory medicine 2008;132(6):907-12.
-
2008: Sampson John H; Akabani Gamal; Archer Gerald E; Berger Mitchel S; Coleman R Edward; Friedman Allan H; Friedman Henry S; Greer Kim; Herndon James E; Kunwar Sandeep; McLendon Roger E; Paolino Alison; Petry Neil A; Provenzale James M; Reardon David A; Wong Terence Z; Zalutsky Michael R; Pastan Ira; Bigner Darell D
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.
Neuro-oncology 2008;10(3):320-9.
-
2008: Reardon David A; Desjardins Annick; Vredenburgh James J; Sathornsumetee Sith; Rich Jeremy N; Quinn Jennifer A; Lagattuta Theodore F; Egorin Merrill J; Gururangan Sridharan; McLendon Roger; Herndon James E; Friedman Allan H; Salvado August J; Friedman Henry S
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
Neuro-oncology 2008;10(3):330-40.
-
2008: Reardon David A; Zalutsky Michael R; Akabani Gamal; Coleman R Edward; Friedman Allan H; Herndon James E; McLendon Roger E; Pegram Charles N; Quinn Jennifer A; Rich Jeremy N; Vredenburgh James J; Desjardins Annick; Guruangan Sridharan; Boulton Susan; Raynor Renee H; Dowell Jeanette M; Wong Terence Z; Zhao Xiao-Guang; Friedman Henry S; Bigner Darell D
A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Neuro-oncology 2008;10(2):182-9.
-
2008: Davis Faith G; Malmer Beatrice S; Aldape Ken; Barnholtz-Sloan Jill S; Bondy Melissa L; Brännström Thomas; Bruner Janet M; Burger Peter C; Collins V Peter; Inskip Peter D; Kruchko Carol; McCarthy Bridget J; McLendon Roger E; Sadetzki Siegal; Tihan Tarik; Wrensch Margaret R; Buffler Patricia A
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(3):484-9.
-
2008: Mitchell Duane A; Xie Weihua; Schmittling Robert; Learn Chris; Friedman Allan; McLendon Roger E; Sampson John H
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.
Neuro-oncology 2008;10(1):10-8.
-
2008: Kovacs Kalman; Scheithauer Bernd W; Lombardero Matilde; McLendon Roger E; Syro Luis V; Uribe Humberto; Ortiz Leon D; Penagos Luis C
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy.
Acta neuropathologica 2008;115(2):261-2.
-
2008: Sathornsumetee Sith; Cao Yiting; Marcello Jennifer E; Herndon James E; McLendon Roger E; Desjardins Annick; Friedman Henry S; Dewhirst Mark W; Vredenburgh James J; Rich Jeremy N
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):271-8.
-
2008: Zalutsky Michael R; Reardon David A; Akabani Gamal; Coleman R Edward; Friedman Allan H; Friedman Henry S; McLendon Roger E; Wong Terence Z; Bigner Darell D
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(1):30-8.
-
2008: Wang Jialiang; Wang Hui; Li Zhizhong; Wu Qiulian; Lathia Justin D; McLendon Roger E; Hjelmeland Anita B; Rich Jeremy N
c-Myc is required for maintenance of glioma cancer stem cells.
PloS one 2008;3(11):e3769.
-
2008: Abou-Donia Mohamed B; El-Masry Eman M; Abdel-Rahman Ali A; McLendon Roger E; Schiffman Susan S
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats.
Journal of toxicology and environmental health. Part A 2008;71(21):1415-29.
-
2007: McLendon Roger E; Turner Kristi; Perkinson Kathryn; Rich Jeremy
Second messenger systems in human gliomas.
Archives of pathology & laboratory medicine 2007;131(10):1585-90.
-
2007: McLendon Roger E; Akabani Gamal; Friedman Henry S; Reardon David A; Cleveland Linda; Cokgor Ilkcan; Herndon James E; Wikstrand Carol; Boulton Susan T; Friedman Allan H; Bigner Darell D; Zalutsky Michael R
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
Nuclear medicine and biology 2007;34(4):405-13.
-
2007: Desjardins Annick; Quinn Jennifer A; Vredenburgh James J; Sathornsumetee Sith; Friedman Allan H; Herndon James E; McLendon Roger E; Provenzale James M; Rich Jeremy N; Sampson John H; Gururangan Sridharan; Dowell Jeannette M; Salvado August; Friedman Henry S; Reardon David A
Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
Journal of neuro-oncology 2007;83(1):53-60.
-
2007: Powers Ciaran J; New Kent C; McLendon Roger E; Friedman Allan H; Fuchs Herbert E
Cerebellopontine angle craniopharyngioma: case report and literature review.
Pediatric neurosurgery 2007;43(2):158-63.
-
2006: Bao Shideng; Wu Qiulian; McLendon Roger E; Hao Yueling; Shi Qing; Hjelmeland Anita B; Dewhirst Mark W; Bigner Darell D; Rich Jeremy N
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Nature 2006;444(7120):756-60.
-
2006: Ochiai Hidenobu; Pernell Chris T; Archer Gary E; Chewning Tracy A; McLendon Roger E; Friedman Henry S; Sampson John H
Treatment of neoplastic meningitis with intrathecal 9-nitro-camptothecin.
Neurologia medico-chirurgica 2006;46(10):485-9; discussion 489-90.
-
2006: Maxwell Jill A; Johnson Stewart P; Quinn Jennifer A; McLendon Roger E; Ali-Osman Francis; Friedman Allan H; Herndon James E; Bierau Katja; Bigley Joseph; Bigner Darell D; Friedman Henry S
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma.
Molecular cancer therapeutics 2006;5(10):2531-9.
-
2006: Sathornsumetee Sith; Hjelmeland Anita B; Keir Stephen T; McLendon Roger E; Batt David; Ramsey Timothy; Yusuff Naeem; Rasheed B K Ahmed; Kieran Mark W; Laforme Andrea; Bigner Darell D; Friedman Henry S; Rich Jeremy N
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
Cancer research 2006;66(17):8722-30.
-
2006: Bao Shideng; Wu Qiulian; Sathornsumetee Sith; Hao Yueling; Li Zhizhong; Hjelmeland Anita B; Shi Qing; McLendon Roger E; Bigner Darell D; Rich Jeremy N
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.
Cancer research 2006;66(16):7843-8.
-
2006: Reardon David A; Quinn Jennifer A; Akabani Gamal; Coleman R Edward; Friedman Allan H; Friedman Henry S; Herndon James E; McLendon Roger E; Pegram Charles N; Provenzale James M; Dowell Jeannette M; Rich Jeremy N; Vredenburgh James J; Desjardins Annick; Sampson John H; Gururangan Sridharan; Wong Terence Z; Badruddoja Michael A; Zhao Xiao-Guang; Bigner Darell D; Zalutsky Michael R
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):912-8.
-
2006: McLendon Roger E
Errors in surgical neuropathology and the influence of cognitive biases: the psychology of intelligence analysis.
Archives of pathology & laboratory medicine 2006;130(5):613-6.
-
2006: Reardon David A; Quinn Jennifer A; Vredenburgh James J; Gururangan Sridharan; Friedman Allan H; Desjardins Annick; Sathornsumetee Sith; Herndon James E; Dowell Jeannette M; McLendon Roger E; Provenzale James M; Sampson John H; Smith Robert P; Swaisland Alan J; Ochs Judith S; Lyons Peggy; Tourt-Uhlig Sandy; Bigner Darell D; Friedman Henry S; Rich Jeremy N
Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):860-8.
-
2006: Reardon David A; Akabani Gamal; Coleman R Edward; Friedman Allan H; Friedman Henry S; Herndon James E; McLendon Roger E; Pegram Charles N; Provenzale James M; Quinn Jennifer A; Rich Jeremy N; Vredenburgh James J; Desjardins Annick; Gururangan Sridharan; Badruddoja Michael; Dowell Jeanette M; Wong Terence Z; Zhao Xiao-Guang; Zalutsky Michael R; Bigner Darell D
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):115-22.
-
2005: Reardon David A; Egorin Merrill J; Quinn Jennifer A; Rich Jeremy N; Gururangan Sridharan; Vredenburgh James J; Desjardins Annick; Sathornsumetee Sith; Provenzale James M; Herndon James E; Dowell Jeannette M; Badruddoja Michael A; McLendon Roger E; Lagattuta Theodore F; Kicielinski Kimberly P; Dresemann Gregor; Sampson John H; Friedman Allan H; Salvado August J; Friedman Henry S
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9359-68.
-
2005: Rich Jeremy N; Sathornsumetee Sith; Keir Stephen T; Kieran Mark W; Laforme Andrea; Kaipainen Arja; McLendon Roger E; Graner Michael W; Rasheed B K Ahmed; Wang Ling; Reardon David A; Ryan Anderson J; Wheeler Catherine; Dimery Isaiah; Bigner Darell D; Friedman Henry S
ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8145-57.
-
2005: Quinn Jennifer A; Desjardins Annick; Weingart Jon; Brem Henry; Dolan M Eileen; Delaney Shannon M; Vredenburgh James; Rich Jeremy; Friedman Allan H; Reardon David A; Sampson John H; Pegg Anthony E; Moschel Robert C; Birch Robert; McLendon Roger E; Provenzale James M; Gururangan Sridharan; Dancey Janet E; Maxwell Jill; Tourt-Uhlig Sandra; Herndon James E; Bigner Darell D; Friedman Henry S
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7178-87.
-
2005: McLendon Roger E; Herndon James E; West Bryan; Reardon David; Wiltshire Rodney; Rasheed B K Ahmed; Quinn Jennifer; Friedman Henry S; Friedman Allan H; Bigner Darell D
Survival analysis of presumptive prognostic markers among oligodendrogliomas.
Cancer 2005;104(8):1693-9.
-
2005: Reardon David A; Quinn Jennifer A; Rich Jeremy N; Desjardins Annick; Vredenburgh James; Gururangan Sridharan; Sathornsumetee Sith; Badruddoja Michael; McLendon Roger; Provenzale James; Herndon James E; Dowell Jeannette M; Burkart Jill L; Newton Herbert B; Friedman Allan H; Friedman Henry S
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Cancer 2005;104(7):1478-86.
-
2005: Akabani Gamal; Reardon David A; Coleman R Edward; Wong Terence Z; Metzler Scott D; Bowsher James E; Barboriak Daniel P; Provenzale James M; Greer Kim L; DeLong David; Friedman Henry S; Friedman Allan H; Zhao Xiao-Guang; Pegram Charles N; McLendon Roger E; Bigner Darell D; Zalutsky Michael R
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1042-51.
-
2005: Rich Jeremy N; Hans Christopher; Jones Beatrix; Iversen Edwin S; McLendon Roger E; Rasheed B K Ahmed; Dobra Adrian; Dressman Holly K; Bigner Darell D; Nevins Joseph R; West Mike
Gene expression profiling and genetic markers in glioblastoma survival.
Cancer research 2005;65(10):4051-8.
-
2005: Di Chunhui; Liao Shaoxi; Adamson David C; Parrett Timothy J; Broderick Daniel K; Shi Qun; Lengauer Christoph; Cummins Jordan M; Velculescu Victor E; Fults Daniel W; McLendon Roger E; Bigner Darell D; Yan Hai
Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
Cancer research 2005;65(3):919-24.
-
2005: Sampson John H; Reardon David A; Friedman Allan H; Friedman Henry S; Coleman R Edward; McLendon Roger E; Pastan Ira; Bigner Darell D
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study.
Neuro-oncology 2005;7(1):90-6.
-
2005: Goudar Ranjit K; Shi Qing; Hjelmeland Mark D; Keir Stephen T; McLendon Roger E; Wikstrand Carol J; Reese Elizabeth D; Conrad Charles A; Traxler Peter; Lane Heidi A; Reardon David A; Cavenee Webster K; Wang Xiao-Fan; Bigner Darell D; Friedman Henry S; Rich Jeremy N
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.
Molecular cancer therapeutics 2005;4(1):101-12.
-
2004: Alexander R T; McLendon R E; Cummings T J
Meningioma with eosinophilic granular inclusions.
Clinical neuropathology 2004;23(6):292-7.
-
2004: Broderick Daniel K; Di Chunhui; Parrett Timothy J; Samuels Yardena R; Cummins Jordan M; McLendon Roger E; Fults Daniel W; Velculescu Victor E; Bigner Darell D; Yan Hai
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas.
Cancer research 2004;64(15):5048-50.
-
2004: Wiltshire Rodney N; Herndon James E; Lloyd Annie; Friedman Henry S; Bigner Darell D; Bigner Sandra H; McLendon Roger E
Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.
The Journal of molecular diagnostics : JMD 2004;6(3):166-79.
-
2004: McLendon Roger E; Rasheed Ahmed; Wiltshire Rodney; Herndon James
Correlation of 1p-19q-defects in human gliomas with the light microscopic appearance of oligodendroglioma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(5):604-5.
-
2004: Cummings T J; George T M; Fuchs H E; McLendon R E
The pathology of extracranial scalp and skull masses in young children.
Clinical neuropathology 2004;23(1):34-43.
-
2004: Rich Jeremy N; Reardon David A; Peery Terry; Dowell Jeannette M; Quinn Jennifer A; Penne Kara L; Wikstrand Carol J; Van Duyn Lauren B; Dancey Janet E; McLendon Roger E; Kao James C; Stenzel Timothy T; Ahmed Rasheed B K; Tourt-Uhlig Sandra E; Herndon James E; Vredenburgh James J; Sampson John H; Friedman Allan H; Bigner Darell D; Friedman Henry S
Phase II trial of gefitinib in recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):133-42.
-
2003: Grossi Peter M; Ochiai Hidenobu; Archer Gary E; McLendon Roger E; Zalutsky Michael R; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5514-20.
-
2003: Sampson John H; Akabani Gamal; Archer Gary E; Bigner Darell D; Berger Mitchel S; Friedman Allan H; Friedman Henry S; Herndon James E; Kunwar Sandeep; Marcus Steve; McLendon Roger E; Paolino Alison; Penne Kara; Provenzale James; Quinn Jennifer; Reardon David A; Rich Jeremy; Stenzel Timothy; Tourt-Uhlig Sandra; Wikstrand Carol; Wong Terence; Williams Roger; Yuan Fan; Zalutsky Michael R; Pastan Ira
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.
Journal of neuro-oncology 2003;65(1):27-35.
-
2003: McLendon Roger E; Halperin Edward C
Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
Cancer 2003;98(8):1745-8.
-
2003: Gururangan Sridharan; McLaughlin Colleen; Quinn Jennifer; Rich Jeremy; Reardon David; Halperin Edward C; Herndon James; Fuchs Herbert; George Timothy; Provenzale James; Watral Melody; McLendon Roger E; Friedman Allan; Friedman Henry S; Kurtzberg Joanne; Vredenbergh James; Martin Paul L
High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2187-91.
-
2003: Quinn Jennifer A; Reardon David A; Friedman Allan H; Rich Jeremy N; Sampson John H; Provenzale James M; McLendon Roger E; Gururangan Sridharan; Bigner Darell D; Herndon James E; Avgeropoulos Nicholas; Finlay Jonathan; Tourt-Uhlig Sandra; Affronti Mary Lou; Evans Brandon; Stafford-Fox Valerie; Zaknoen Sara; Friedman Henry S
Phase II trial of temozolomide in patients with progressive low-grade glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(4):646-51.
-
2002: Heimberger A B; Wiltshire R N; Bronec R; McLendon R E; Cummings T J
Biphasic malignant meningioma: a comparative genomic hybridization study.
Clinical neuropathology 2002;21(6):258-64.
-
2002: Heimberger Amy B; Learn Chris A; Archer Gary E; McLendon Roger E; Chewning Tracy A; Tuck Frank L; Pracyk John B; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3496-502.
-
2002: Akabani Gamal; McLendon Roger E; Bigner Darrell D; Zalutsky Michael R
Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: theoretical analysis.
International journal of radiation oncology, biology, physics 2002;54(4):1259-75.
-
2002: Rasheed Ahmed; Herndon James E; Stenzel Timothy T; Raetz Jacqueline G M; Kendelhardt Jason; Friedman Henry S; Friedman Allan H; Bigner Darell D; Bigner Sandra H; McLendon Roger E
Molecular markers of prognosis in astrocytic tumors.
Cancer 2002;94(10):2688-97.
-
2002: Quinn Jennifer A; Pluda James; Dolan M Eileen; Delaney Shannon; Kaplan Richard; Rich Jeremy N; Friedman Allan H; Reardon David A; Sampson John H; Colvin O Michael; Haglund Michael M; Pegg Anthony E; Moschel Robert C; McLendon Roger E; Provenzale James M; Gururangan Sridharan; Tourt-Uhlig Sandra; Herndon James E; Bigner Darell D; Friedman Henry S
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2277-83.
-
2002: Aldosari Naji; Bigner Sandra H; Burger Peter C; Becker Laurence; Kepner James L; Friedman Henry S; McLendon Roger E
MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
Archives of pathology & laboratory medicine 2002;126(5):540-4.
-
2002: Turner Christopher D; Gururangan Sridharan; Eastwood James; Bottom Krystal; Watral Melody; Beason Rodney; McLendon Roger E; Friedman Allan H; Tourt-Uhlig Sandra; Miller Langdon L; Friedman Henry S
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Neuro-oncology 2002;4(2):102-8.
-
2002: Aldosari Naji; Wiltshire Rodney N; Dutra Amalia; Schrock Evelin; McLendon Roger E; Friedman Henry S; Bigner Darell D; Bigner Sandra H
Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
Neuro-oncology 2002;4(2):75-85.
-
2002: Reardon David A; Akabani Gamal; Coleman R Edward; Friedman Allan H; Friedman Henry S; Herndon James E; Cokgor Ilkcan; McLendon Roger E; Pegram Charles N; Provenzale James M; Quinn Jennifer A; Rich Jeremy N; Regalado Lorna V; Sampson John H; Shafman Timothy D; Wikstrand Carol J; Wong Terence Z; Zhao Xiao-Guang; Zalutsky Michael R; Bigner Darell D
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1389-97.
-
2002: Heimberger Amy B; Archer Gary E; Crotty Laura E; McLendon Roger E; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma.
Neurosurgery 2002;50(1):158-64; discussion 164-6.
-
2002: McLendon Roger E; Provenzale James
Glioneuronal tumors of the central nervous system.
Brain tumor pathology 2002;19(2):51-8.
-
2001: Eastwood J D; Turner D A; McLendon R E; Provenzale J M
Diffusion-weighted MR imaging in a patient with spinal meningioma.
AJR. American journal of roentgenology 2001;177(6):1479-81.
-
2001: Cummings T J; Burchette J L; McLendon R E
CD34 and dural fibroblasts: the relationship to solitary fibrous tumor and meningioma.
Acta neuropathologica 2001;102(4):349-54.
-
2001: Gururangan S; Cokgor L; Rich J N; Edwards S; Affronti M L; Quinn J A; Herndon J E; Provenzale J M; McLendon R E; Tourt-Uhlig S; Sampson J H; Stafford-Fox V; Zaknoen S; Early M; Friedman A H; Friedman H S
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
Neuro-oncology 2001;3(4):246-50.
-
2001: Cummings T J; Ebert R H; Provenzale J; McLendon R E
March 2000: A 16 year old female with a cerebellar mass.
Brain pathology (Zurich, Switzerland) 2001;11(3):391-3.
-
2001: Rich J N; Guo C; McLendon R E; Bigner D D; Wang X F; Counter C M
A genetically tractable model of human glioma formation.
Cancer research 2001;61(9):3556-60.
-
2001: Cummings T J; Hulette C M; Bigner S H; Riggins G J; McLendon R E
Ham56-immunoreactive macrophages in untreated infiltrating gliomas.
Archives of pathology & laboratory medicine 2001;125(5):637-41.
-
2001: Cummings T J; Bentley R C; McLendon R E
Pathologic quiz case: pituitary mass in a 48-year-old woman.
Archives of pathology & laboratory medicine 2001;125(2):299-300.
-
2000: Cokgor I; Akabani G; Kuan C T; Friedman H S; Friedman A H; Coleman R E; McLendon R E; Bigner S H; Zhao X G; Garcia-Turner A M; Pegram C N; Wikstrand C J; Shafman T D; Herndon J E; Provenzale J M; Zalutsky M R; Bigner D D
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3862-72.
-
2000: Heimberger A B; Archer G E; McLendon R E; Hulette C; Friedman A H; Friedman H S; Bigner D D; Sampson J H
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4148-53.
-
2000: Friedman H S; Pluda J; Quinn J A; Ewesuedo R B; Long L; Friedman A H; Cokgor I; Colvin O M; Haglund M M; Ashley D M; Rich J N; Sampson J; Pegg A E; Moschel R C; McLendon R E; Provenzale J M; Stewart E S; Tourt-Uhlig S; Garcia-Turner A M; Herndon J E; Bigner D D; Dolan M E
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3522-8.
-
2000: McLendon R E; Wikstrand C J; Matthews M R; Al-Baradei R; Bigner S H; Bigner D D
Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2000;48(8):1103-10.
-
2000: Cummings T J; Provenzale J M; Hunter S B; Friedman A H; Klintworth G K; Bigner S H; McLendon R E
Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Acta neuropathologica 2000;99(5):563-70.
-
2000: Aldosari N; Rasheed B K; McLendon R E; Friedman H S; Bigner D D; Bigner S H
Characterization of chromosome 17 abnormalities in medulloblastomas.
Acta neuropathologica 2000;99(4):345-51.
-
2000: Akabani G; Cokgor I; Coleman R E; González Trotter D; Wong T Z; Friedman H S; Friedman A H; Garcia-Turner A; Herndon J E; DeLong D; McLendon R E; Zhao X G; Pegram C N; Provenzale J M; Bigner D D; Zalutsky M R
Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy.
International journal of radiation oncology, biology, physics 2000;46(4):947-58.
-
2000: Provenzale J M; Ali U; Barboriak D P; Kallmes D F; Delong D M; McLendon R E
Comparison of patient age with MR imaging features of gangliogliomas.
AJR. American journal of roentgenology 2000;174(3):859-62.
-
2000: Heimberger A B; Crotty L E; Archer G E; McLendon R E; Friedman A; Dranoff G; Bigner D D; Sampson J H
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.
Journal of neuroimmunology 2000;103(1):16-25.
-
1999: Nuckols J D; Liu K; Burchette J L; McLendon R E; Traweek S T
Primary central nervous system lymphomas: a 30-year experience at a single institution.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(12):1167-73.
-
1999: Lal A; Lash A E; Altschul S F; Velculescu V; Zhang L; McLendon R E; Marra M A; Prange C; Morin P J; Polyak K; Papadopoulos N; Vogelstein B; Kinzler K W; Strausberg R L; Riggins G J
A public database for gene expression in human cancers.
Cancer research 1999;59(21):5403-7.
-
1999: Cummings T J; Bentley R C; Gray L; Check W E; Lanier T E; McLendon R E
Meningioma of the fourth ventricle.
Clinical neuropathology 1999;18(5):265-9.
-
1999: Archer G E; Sampson J H; Lorimer I A; McLendon R E; Kuan C T; Friedman A H; Friedman H S; Pastan I H; Bigner D D
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2646-52.
-
1999: McLendon R E; Archer G E; Larsen R H; Akabani G; Bigner D D; Zalutsky M R
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.
International journal of radiation oncology, biology, physics 1999;45(2):491-9.
-
1999: Bigner S H; Matthews M R; Rasheed B K; Wiltshire R N; Friedman H S; Friedman A H; Stenzel T T; Dawes D M; McLendon R E; Bigner D D
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
The American journal of pathology 1999;155(2):375-86.
-
1999: Cummings T J; Hulette C M; Longee D C; Bottom K S; McLendon R E; Chu C T
Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis.
Clinical neuropathology 1999;18(4):190-7.
-
1999: Sampson J H; Archer G E; Villavicencio A T; McLendon R E; Friedman A H; Bishop W R; Bigner D D; Friedman H S
Treatment of neoplastic meningitis with intrathecal temozolomide.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1183-8.
-
1999: Friedman H S; Petros W P; Friedman A H; Schaaf L J; Kerby T; Lawyer J; Parry M; Houghton P J; Lovell S; Rasheed K; Cloughsey T; Stewart E S; Colvin O M; Provenzale J M; McLendon R E; Bigner D D; Cokgor I; Haglund M; Rich J; Ashley D; Malczyn J; Elfring G L; Miller L L
Irinotecan therapy in adults with recurrent or progressive malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1516-25.
-
1999: Dodd L G; Marom E M; Dash R C; Matthews M R; McLendon R E
Fine-needle aspiration cytology of "ancient" schwannoma.
Diagnostic cytopathology 1999;20(5):307-11.
-
1999: Provenzale J M; Arata M A; Turkington T G; McLendon R E; Coleman R E
Gangliogliomas: characterization by registered positron emission tomography-MR images.
AJR. American journal of roentgenology 1999;172(4):1103-7.
-
1999: Dash R C; Provenzale J M; McComb R D; Perry D A; Longee D C; McLendon R E
Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature.
Archives of pathology & laboratory medicine 1999;123(4):342-5.
-
1999: Friedman H S; Kerby T; Fields S; Zilisch J E; Graden D; McLendon R E; Houghton P J; Arbuck S; Cokgor I; Friedman A H
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.
Cancer 1999;85(5):1160-5.
-
1999: McLendon R E; Friedman H S; Fuchs H E; Kun L E; Bigner S H
Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study.
Histopathology 1999;34(2):154-62.
-
1999: Bigner S H; Rasheed B K; Wiltshire R; McLendon R E
Morphologic and molecular genetic aspects of oligodendroglial neoplasms.
Neuro-oncology 1999;1(1):52-60.
-
1999: Archer G E; Sampson J H; McLendon R E; Friedman A H; Colvin O M; Rose M; Sands H; McCullough W; Fuchs H E; Bigner D D; Friedman H S
Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats.
Journal of neuro-oncology 1999;44(3):233-41.
-
1998: Friedman H S; McLendon R E; Kerby T; Dugan M; Bigner S H; Henry A J; Ashley D M; Krischer J; Lovell S; Rasheed K; Marchev F; Seman A J; Cokgor I; Rich J; Stewart E; Colvin O M; Provenzale J M; Bigner D D; Haglund M M; Friedman A H; Modrich P L
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3851-7.
-
1998: Koen J L; McLendon R E; George T M
Intradural spinal teratoma: evidence for a dysembryogenic origin. Report of four cases.
Journal of neurosurgery 1998;89(5):844-51.
-
1998: Friedman H S; Kokkinakis D M; Pluda J; Friedman A H; Cokgor I; Haglund M M; Ashley D M; Rich J; Dolan M E; Pegg A E; Moschel R C; McLendon R E; Kerby T; Herndon J E; Bigner D D; Schold S C
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(11):3570-5.
-
1998: Lee S E; Johnson S P; Hale L P; Li J; Bullock N; Fuchs H; Friedman A; McLendon R; Bigner D D; Modrich P; Friedman H S
Analysis of DNA mismatch repair proteins in human medulloblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1415-9.
-
1998: Bigner D D; Brown M T; Friedman A H; Coleman R E; Akabani G; Friedman H S; Thorstad W L; McLendon R E; Bigner S H; Zhao X G; Pegram C N; Wikstrand C J; Herndon J E; Vick N A; Paleologos N; Cokgor I; Provenzale J M; Zalutsky M R
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2202-12.
-
1998: McLendon R E; Cleveland L; Pegram C; Bigner S H; Bigner D D; Friedman H S
Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas.
Laboratory investigation; a journal of technical methods and pathology 1998;78(5):643-4.
-
1998: McCowage G B; Friedman H S; Moghrabi A; Kerby T; Ferrell L; Stewart E; Duncan-Brown M; Fuchs H E; Tien R; McLendon R E; Meier L; Kurtzberg J; Ashley D; Colvin O M; Longee D C
Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas.
Medical and pediatric oncology 1998;30(2):75-80.
-
1998: Slavik T; Bentley R C; Gray L; Fuchs H E; McLendon R E
Solitary fibrous tumor of the meninges occurring after irradiation of a mixed germ cell tumor of the pineal gland.
Clinical neuropathology 1998;17(1):55-60.
-
1997: Rasheed B K; Stenzel T T; McLendon R E; Parsons R; Friedman A H; Friedman H S; Bigner D D; Bigner S H
PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
Cancer research 1997;57(19):4187-90.
-
1997: Wikstrand C J; McLendon R E; Friedman A H; Bigner D D
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
Cancer research 1997;57(18):4130-40.
-
1997: Bigner S H; McLendon R E; Fuchs H; McKeever P E; Friedman H S
Chromosomal characteristics of childhood brain tumors.
Cancer genetics and cytogenetics 1997;97(2):125-34.
-
1997: McLendon R E; Bentley R C; Parisi J E; Tien R D; Harrison J C; Tarbell N J; Billitt A L; Gualtieri R J; Friedman H S
Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literature.
Archives of pathology & laboratory medicine 1997;121(5):485-92.
-
1997: Ashraf R; Bentley R C; Awan A N; McLendon R E; Ragozzino M W
Implantation metastasis of primary malignant rhabdoid tumor of the brain in an adult (one case report).
Medical and pediatric oncology 1997;28(3):223-7.
-
1997: Provenzale J M; Schaefer P; Traweek S T; Ferry J; Moore J O; Friedman A H; McLendon R E
Craniocerebral plasmacytoma: MR features.
AJNR. American journal of neuroradiology 1997;18(2):389-92.
-
1997: Moghrabi A; Tien R; Fuchs H; Longee D; McLendon R; Friedman H S
False positive images in the follow-up of patients with brain tumors.
Medical and pediatric oncology 1997;28(2):127-31.
-
1996: McCowage G; Tien R; McLendon R; Felsberg G; Fuchs H; Graham M L; Kurtzberg J; Moghrabi A; Ferrell L; Kerby T; Duncan-Brown M; Stewart E; Robertson P L; Colvin O M; Golembe B; Bigner D D; Friedman H S
Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide.
Medical and pediatric oncology 1996;27(1):32-9.
-
1996: Brown M T; Coleman R E; Friedman A H; Friedman H S; McLendon R E; Reiman R; Felsberg G J; Tien R D; Bigner S H; Zalutsky M R; Zhao X G; Wikstrand C J; Pegram C N; Herndon J E; Vick N A; Paleologos N; Fredericks R K; Schold S C; Bigner D D
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(6):963-72.
-
1996: Ashley D M; Longee D; Tien R; Fuchs H; Graham M L; Kurtzberg J; Casey J; Olson J; Meier L; Ferrell L; Kerby T; Duncan-Brown M; Stewart E; Colvin O M; Pipas J M; McCowage G; McLendon R; Bigner D D; Friedman H S
Treatment of patients with pineoblastoma with high dose cyclophosphamide.
Medical and pediatric oncology 1996;26(6):387-92.
-
1996: McLendon R E; Fung K M; Bentley R C; Ahmed Rasheed B K; Trojanowski J Q; Bigner S H; Bigner D D; Friedman H S
Production and characterization of two ependymoma xenografts.
Journal of neuropathology and experimental neurology 1996;55(5):540-8.
-
1996: Provenzale J M; McLendon R E
Spinal angiolipomas: MR features.
AJNR. American journal of neuroradiology 1996;17(4):713-9.
-
1996: McLendon R E; Archer G E; Garg P K; Bigner D D; Zalutsky M R
Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis.
International journal of radiation oncology, biology, physics 1996;35(1):69-80.
-
1995: Bigner D D; Archer G E; McLendon R E; Friedman H S; Fuchs H E; Pai L H; Herndon J E; Pastan I H
Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1545-55.
-
1995: Kurpad S N; Zhao X G; Wikstrand C J; Batra S K; McLendon R E; Bigner D D
Tumor antigens in astrocytic gliomas.
Glia 1995;15(3):244-56.
-
1995: Kurpad S N; Friedman H S; Archer G E; McLendon R E; Petros W M; Fuchs H E; Guaspari A; Bigner D D
Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Cancer research 1995;55(17):3803-9.
-
1995: Felsberg G J; Tien R D; McLendon R E
Frontoethmoidal giant cell reparative granuloma.
AJNR. American journal of neuroradiology 1995;16(7):1551-4.
-
1995: Wikstrand C J; Hale L P; Batra S K; Hill M L; Humphrey P A; Kurpad S N; McLendon R E; Moscatello D; Pegram C N; Reist C J
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Cancer research 1995;55(14):3140-8.
-
1995: Rasheed B K; McLendon R E; Friedman H S; Friedman A H; Fuchs H E; Bigner D D; Bigner S H
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Oncogene 1995;10(11):2243-6.
-
1995: Foltz R M; McLendon R E; Friedman H S; Dodge R K; Bigner D D; Dewhirst M W
A pial window model for the intracranial study of human glioma microvascular function.
Neurosurgery 1995;36(5):976-84; discussion 984-5.
-
1995: Hitchcock M G; Ellington K S; Friedman A H; Provenzaie J M; McLendon R E
Shadow cells in an intracranial dermoid cyst.
Archives of pathology & laboratory medicine 1995;119(4):371-3.
-
1995: Pastan I H; Archer G E; McLendon R E; Friedman H S; Fuchs H E; Wang Q C; Pai L H; Herndon J; Bigner D D
Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2765-9.
-
1995: Provenzale J M; Weber A L; Klintworth G K; McLendon R E
Radiologic-pathologic correlation. Bilateral retinoblastoma with coexistent pinealoblastoma (trilateral retinoblastoma).
AJNR. American journal of neuroradiology 1995;16(1):157-65.
-
1995: Lee V S; Provenzale J M; Fuchs H E; Osumi A; McLendon R E
Post-traumatic epidermoid cyst: CT appearance.
Journal of computer assisted tomography 1995;19(1):153-5.
-
1995: Batra S K; McLendon R E; Koo J S; Castelino-Prabhu S; Fuchs H E; Krischer J P; Friedman H S; Bigner D D; Bigner S H
Prognostic implications of chromosome 17p deletions in human medulloblastomas.
Journal of neuro-oncology 1995;24(1):39-45.
-
1995: Bigner D D; Brown M; Coleman R E; Friedman A H; Friedman H S; McLendon R E; Bigner S H; Zhao X G; Wikstrand C J; Pegram C N
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.
Journal of neuro-oncology 1995;24(1):109-22.
-
1994: Zalutsky M R; McLendon R E; Garg P K; Archer G E; Schuster J M; Bigner D D
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
Cancer research 1994;54(17):4719-25.
-
1994: Friedman H S; Archer G E; McLendon R E; Schuster J M; Colvin O M; Guaspari A; Blum R; Savina P A; Fuchs H E; Bigner D D
Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats.
Cancer research 1994;54(17):4710-4.
-
1994: Osumi A K; Mclendon R E; Tien R D; Friedman H S; Graham M; Hockenberger B; Halperin E C; Oakes W J
Well differentiated astrocytoma occurring nine years after radiation therapy for medulloblastoma.
Clinical neuropathology 1994;13(5):281-5.
-
1994: McLendon R E; Bigner D D
Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations.
Brain pathology (Zurich, Switzerland) 1994;4(3):221-8.
-
1994: Rasheed B K; McLendon R E; Herndon J E; Friedman H S; Friedman A H; Bigner D D; Bigner S H
Alterations of the TP53 gene in human gliomas.
Cancer research 1994;54(5):1324-30.
-
1994: Moghrabi A; Friedman H S; McLendon R; Hockenberger B; Tien R D; Halperin E C; Oakes W J
Arteriovenous malformation mimicking recurrent medulloblastoma.
Medical and pediatric oncology 1994;22(2):140-3.
-
1993: Furie D M; Felsberg G J; Tien R D; Friedman H S; Fuchs H; McLendon R
MRI of gangliocytoma of cerebellum and spinal cord.
Journal of computer assisted tomography 1993;17(3):488-91.
-
1993: Schuster J M; Friedman H S; Archer G E; Fuchs H E; McLendon R E; Colvin O M; Bigner D D
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Cancer research 1993;53(10 Suppl):2338-43.
-
1993: Wikstrand C J; Longee D C; McLendon R E; Fuller G N; Friedman H S; Fredman P; Svennerholm L; Bigner D D
Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Cancer research 1993;53(1):120-6.
-
1988: McLendon R E; Oakes W J; Heinz E R; Yeates A E; Burger P C
Adipose tissue in the filum terminale: a computed tomographic finding that may indicate tethering of the spinal cord.
Neurosurgery 1988;22(5):873-6.
-
1986: McLendon R E; Burger P C; Pegram C N; Eng L F; Bigner D D
The immunohistochemical application of three anti-GFAP monoclonal antibodies to formalin-fixed, paraffin-embedded, normal and neoplastic brain tissues.
Journal of neuropathology and experimental neurology 1986;45(6):692-703.
Sign-in to see more
